Drugs / H.pylori vaccines
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00736476 | Oct 2008 → Mar 2010 | Helicobacter pylori infectious disease | Novartis Vaccines | Completed | Missed primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | H.pylori vaccines | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00736476 ↗ |
| Modality | Vaccine | “a vaccine composed of three recombinant Helicobacter pylori antigens” PMID 30042064 ↗ Jul 2018 |
| Route | Intramuscular | “three intramuscular doses of either placebo or vaccine at 0, 1, and 2 months” PMID 30042064 ↗ Jul 2018 |